A detailed history of Quadrant Capital Group LLC transactions in Insmed Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 15 shares of INSM stock, worth $1,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 15 -0.0%
Holding current value
$1,107
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$16.44 - $21.1 $131 - $168
-8 Reduced 34.78%
15 $0
Q4 2022

Feb 10, 2023

BUY
$16.98 - $23.15 $390 - $532
23 New
23 $0
Q1 2022

May 06, 2022

SELL
$20.42 - $28.13 $122 - $168
-6 Closed
0 $0
Q4 2021

Feb 01, 2022

SELL
$25.89 - $33.45 $621 - $802
-24 Reduced 80.0%
6 $0
Q3 2021

Nov 12, 2021

BUY
$22.46 - $29.47 $673 - $884
30 New
30 $1,000
Q2 2020

Aug 13, 2020

SELL
$14.11 - $29.42 $112 - $235
-8 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$13.63 - $33.98 $109 - $271
8 New
8 $0

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.